Results 131 to 140 of about 28,010 (204)

Assessment of Podocyte Function

Kidney and Blood Pressure Research, 1997
openaire   +2 more sources

Interferon α-induced HERC6 provokes podocyte dysfunction via mitotic catastrophe in lupus nephritis. [PDF]

Arthritis Res Ther
Wei X, Wang S, Peng W, Hang Y, Yang Q, Sun S, Meng D, Nie M, Yao G, Sun L.   +9 more
europepmc   +1 more source

Podocyte specific knockout (KO) of the natriuretic peptide clearance receptor (NPRC) attenuates diabetic kidney disease (DKD). [PDF]

Physiol Rep
Wang L, Tang Y, Dai Q, Buckley AF, Spurney RF.   +4 more
europepmc   +1 more source

Injury-induced paracrine effects on the podocyte's transcriptome. [PDF]

Am J Physiol Renal Physiol
Zeng Y, Schweickart RA, Sharara J, Maggiore JC, Loretz CJ, Hukriede NA, Pippin JW, Theberge AB, Wessely O, Shankland SJ.   +9 more
europepmc   +1 more source

Ectopic lipid deposition in kidney diseases: mechanisms in specific cell types and therapeutic strategies. [PDF]

Front Endocrinol (Lausanne)
Zhong Q, Zhang Y, Sun D, Peng J, Zhang P, Wang R, Cao L, Chen H, Wu C, He Z.   +9 more
europepmc   +1 more source

Astragaloside IV Alleviates Lupus Nephritis by Inhibiting Podocyte Ferroptosis via the PI3K/AKT/Nrf2 Pathway. [PDF]

Drug Des Devel Ther
Tang Z, Cheng L, Li M, Huang C.
europepmc   +1 more source

An Inducible hiPSC-Derived Human Podocyte Model for Functional Analysis of TRPC6 Variants Associated with FSGS. [PDF]

Cells
Batool L, Hariharan K, Stölting G, Zhong T, Tsvetkov D, Gossen M, Kurtz A.   +6 more
europepmc   +1 more source

Molecular Mechanisms of APOL1-Associated Kidney Disease. [PDF]

Int J Mol Sci
Delrue C, Speeckaert R, Speeckaert MM.
europepmc   +1 more source

Molecular mechanisms and novel therapeutic targets of diabetic kidney disease. [PDF]

Chin Med J (Engl)
Xu Z, Yuan Q, Zhang C.
europepmc   +1 more source

ARP3 in podocyte development [PDF]

Nature Reviews Nephrology, 2018
openaire   +2 more sources